MyFinsight
Home
Blog
About
Contact
Download
Download image
Total net loss
attributable to common...
-$6,327K
Net loss
-$6,323K
Finance income
$270K
Operating loss
-$6,592K
General and
administrative
$2,210K
Research and development
$4,383K
Back
Back
Income Statement
source: myfinsight.com
Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma, Inc. (NVCT)